Detalhe da pesquisa
1.
Novel Therapeutic Options for Small Cell Lung Cancer.
Curr Oncol Rep
; 25(11): 1277-1294, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870696
2.
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective.
Int J Mol Sci
; 24(15)2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37569269
3.
Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
Ann Hepatol
; 27(5): 100737, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809836
4.
Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review.
Future Oncol
; 15(9): 989-994, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30681378
5.
Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab.
Cancer Immunol Immunother
; 67(9): 1349-1353, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29947960
6.
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting.
Heliyon
; 10(7): e29272, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38617925
7.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Eur J Cancer
; 202: 114006, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489861
8.
Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
Cancers (Basel)
; 15(3)2023 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765647
9.
Epidemiology, Patients' Journey and Healthcare Costs in Early-Stage Non-Small-Cell Lung Carcinoma: A Real-World Evidence Analysis in Italy.
Pharmaceuticals (Basel)
; 16(3)2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36986463
10.
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion.
Curr Oncol
; 30(11): 10033-10042, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999149
11.
Sneaky Diagnosis of Pleural Malignant Mesothelioma in Thoracic Surgery: All That Glitters Is Not Gold.
J Clin Med
; 11(11)2022 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35683612
12.
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons.
Front Med (Lausanne)
; 9: 989405, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36530878
13.
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 14(24)2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551550
14.
RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center.
Per Med
; 19(5): 395-401, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35801400
15.
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer.
Cancers (Basel)
; 13(1)2021 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406752
16.
What are the options for non-small-cell lung cancer patients post second-line therapy?
Future Oncol
; 11(17): 2379-82, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26270000
17.
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.
Eur J Cancer
; 130: 155-167, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32220780
18.
Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial.
Clin Cancer Res
; 25(24): 7312-7319, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416808
19.
[Metastatic lung adenocarcinoma. Nivolumab as second line treatment: between unresolved issues and promising future. A case report.] / Adenocarcinoma polmonare metastatico. Il nivolumab come trattamento di seconda linea: tra problemi irrisolti e un promettente futuro. Un caso clinico.
Recenti Prog Med
; 109(3): 197e-201e, 2018 Mar.
Artigo
em Italiano
| MEDLINE | ID: mdl-29565054
20.
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection.
Crit Rev Oncol Hematol
; 129: 27-39, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30097235